MedTrace Logo

Role of SGLT2I in Patients With Myocardial Infarction

NCT06245980 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2024-02-08

No results posted yet for this study

Summary

Role of sglt2I in diabetic patients with myocardial infarction

Conditions

Interventions

DRUG

SGLT2 inhibitor

According to whether SGLT2i was used

Sponsors & Collaborators

  • Dongying Zhang

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2024-02-28
Completion
2024-03-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06245980 on ClinicalTrials.gov